profit from every $100 of sales.
$0$100
Harvard Ave Acquisition
$10.29+0.00% today
+4.1% in 1 year
1-year low $9.881-year high $10.30
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay $292.04 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Harvard Ave Acquisition vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Harvard Ave Acquisition | 292.0× · No profit yet | ||
 Churchill Capital Corp X | No profit yet | ||
 Drugs Made In America Acquisition II | 155.8× · No profit yet | ||
 Bain Capital GSS Investment Cor | No profit yet | ||
 Cantor Equity Partners IV | 96.3× · No profit yet |
AI analysis
An AI analyst reads Harvard Ave Acquisition's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2025 |
|---|---|
| 0 | |
| – | |
| -0 | |
| -0 | |
| 1 | |
| 0.09 | |
| – | |
| – | |
| – |
Balance sheet
| In millions of USD | 2025 |
|---|---|
| Total assets | 147 |
| Cash | – |
| Total debt | 0 |
| Total liabilities | 5 |
| 142 | |
| 8 | |
| -0.2% | |
| 0.5% |
Cash flow
| In millions of USD | 2025 |
|---|---|
| -1 | |
| – | |
| -1 | |
| Dividends paid | – |
| – | |
| – |
Valuation
- 292.0×
- –
- –
- 1.5×
- –
- –
- –
- -0.6%
- 0.3%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- -0.2%
- -0.2%
- -3,522.6%
- 0.5%
- -0.0%
- –
Growth
- –
- –
- −38,830,402.7%
- –
- −86.3%
Financial health
- -0.0×
- 0.00
- 0.0%
- –
- 2.34
- 1.91
- 0.00
How it ranks in Financial Services
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 13%of 848
Bottom 6%of 728
Bottom 1%of 880
Bottom 16%of 932
News
Harvard Cut Nvidia by a Third and Bought AMDYahoo Finance · Nov 14, 2026Harvard Now Has $68 Billion, and Its Largest Stock Holding Is SpaceXYahoo Finance · Oct 16, 2026Harvard's Judgment Professor: Numbers Don't Make Decisions; People DoYahoo Finance · Sep 24, 2026Michael Burry Flags New AI Chip Startup By Harvard Dropouts As ‘Serious Competition’ For NvidiaYahoo Finance · Aug 19, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
32No pass
Benjamin Graham
75Pass
Philip Fisher
31No pass
Peter Lynch
60Pass
Joel Greenblatt
1No pass
Charlie Munger
22No pass
Terry Smith
21No pass
Questions about Harvard Ave Acquisition
Is Harvard Ave Acquisition a good stock to buy?
A business with weak numbers that is not profitable yet. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Harvard Ave Acquisition AI analysis
What does Harvard Ave Acquisition do?
Harvard Ave Acquisition Corporation does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. It is in Shell Companies.
Does Harvard Ave Acquisition pay a dividend?
No. Harvard Ave Acquisition does not pay a dividend at the moment.
Is Harvard Ave Acquisition stock halal?
Questionable. Harvard Ave Acquisition sits in a grey zone: scholars disagree about its industry. How we check
How has Harvard Ave Acquisition stock done over the past year?
Up 4.1% over the past twelve months, to $10.29. It traded between $9.88 and $10.30, close to its high.
Who are Harvard Ave Acquisition's competitors?
The largest listed companies in the same industry are Churchill Capital Corp X, Drugs Made In America Acquisition II, Bain Capital GSS Investment Cor and Cantor Equity Partners IV. The peers table on this page compares their profit, growth and price with Harvard Ave Acquisition's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.